top of page
Report Summary
Market Overview

Global Sepsis Diagnosis Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Sepsis Diagnosis Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Technology (Molecular Diagnostics, Microbiology, Immunoassay, and Other Technologies), Product (Instruments, Assays and Reagents, and Other Products), Diagnostic Method (Conventional Diagnostics, and Automated Diagnostics), Pathogen (Bacterial Sepsis, Fungal Sepsis, and Other Pathogens), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Market Overview


The Global Sepsis Diagnosis Market was valued at USD 1,825.5 million in 2023 and is expected to reach USD 3,664.2 million by 2031 while growing at a CAGR of 9.1% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global sepsis diagnosis market growth. Early and accurate diagnosis of sepsis, a life-threatening condition marked by a dysregulated immune response to infection resulting in organ dysfunction, is crucial for timely initiation of treatment and improved patient outcomes.


Technological advancements in diagnostic testing, such as molecular diagnostics, biomarker assays, and rapid point-of-care tests, along with a growing focus on precision medicine, propel the sepsis diagnostics market forward. Nonetheless, challenges such as variability in sepsis definitions and guidelines, as well as cost constraints, could hinder market growth.


Furthermore, the global sepsis diagnosis industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Technology Analysis


The Global Sepsis Diagnosis Market is segmented among Molecular Diagnostics, Microbiology, Immunoassay, and Other Technologies, based on Technology. In 2023, Microbiology accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Product Analysis


The Global Sepsis Diagnosis Market is segmented among Instruments, Assays and Reagents, and Other Products, based on Product. In 2023, Instruments accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Sepsis Diagnosis Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Abbott Laboratories Inc., Axis-Shield Diagnostics Ltd, Becton, Dickinson, and Company, BioMerieux SA, Bruker Corporation, Cube Dx GmbH, Danaher Corporation, EKF Diagnostics, F. Hoffmann-LA Roche Ltd, and Immunexpress Inc.


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Sepsis Diagnosis Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Sepsis Diagnosis Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Sepsis Diagnosis Market Segmentation, By Technology

  • Global Sepsis Diagnosis Market Share Analysis, By Technology

  • Global Sepsis Diagnosis Market Growth Analysis, By Technology

  • Global Sepsis Diagnosis Market Trends, By Technology

o Molecular Diagnostics

o Microbiology

o Immunoassay

o Other Technologies

6. Global Sepsis Diagnosis Market Segmentation, By Product

  • Global Sepsis Diagnosis Market Share Analysis, By Product

  • Global Sepsis Diagnosis Market Growth Analysis, By Product

  • Global Sepsis Diagnosis Market Trends, By Product

o Instruments

o Assays and Reagents

o Other Products

7. Global Sepsis Diagnosis Market Segmentation, By Diagnostic Method

  • Global Sepsis Diagnosis Market Share Analysis, By Diagnostic Method

  • Global Sepsis Diagnosis Market Growth Analysis, By Diagnostic Method

  • Global Sepsis Diagnosis Market Trends, By Diagnostic Method

o Conventional Diagnostics

o Automated Diagnostics

8. Global Sepsis Diagnosis Market Segmentation, By Pathogen

  • Global Sepsis Diagnosis Market Share Analysis, By Pathogen

  • Global Sepsis Diagnosis Market Growth Analysis, By Pathogen

  • Global Sepsis Diagnosis Market Trends, By Pathogen

o Bacterial Sepsis

o Fungal Sepsis

o Other Pathogens

9. Global Sepsis Diagnosis Market Segmentation, By Region

  • Global Sepsis Diagnosis Market Share Analysis, By Region

  • Global Sepsis Diagnosis Market Growth Analysis, By Region

  • Global Sepsis Diagnosis Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

10. Competitive Landscape

  • Abbott Laboratories Inc.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Axis-Shield Diagnostics Ltd

  • Becton, Dickinson, and Company

  • BioMerieux SA

  • Bruker Corporation

  • Cube Dx GmbH

  • Danaher Corporation

  • EKF Diagnostics

  • F. Hoffmann-LA Roche Ltd

  • Immunexpress Inc.

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page